Related Experiment Video
Updated: Aug 6, 2026
04:48
Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
Published on: March 24, 2022
A multitarget ruthenium-clotrimazole complex eradicates MRSA through membrane disruption, DNA intercalation, and ROS
Xiaoyin Wu1, Jinhao Li1, Wentao Lei1
1Key Laboratory for Biobased Materials and Energy of Ministry of Education, College of Materials and Chemical Engineering, South China Agricultural University, Guangzhou 510642, China.
Bioorganic Chemistry
|July 20, 2026
Summary
A novel ruthenium complex, Ru-ctz, shows potent activity against methicillin-resistant Staphylococcus aureus (MRSA). This new agent disrupts bacterial membranes, DNA, and biofilms, offering a promising solution for antibiotic resistance.
Area of Science:
- Medicinal Chemistry
- Antimicrobial Resistance
- Coordination Chemistry
Background:
- Antibiotic resistance is a growing global health crisis, demanding novel therapeutic agents.
- Existing treatments face challenges due to resistance development and limited efficacy.
- Ruthenium complexes offer potential as new antimicrobial agents due to their diverse coordination chemistry.
Purpose of the Study:
- To synthesize and characterize novel ruthenium(II) complexes with imidazole-based ligands.
- To evaluate the antimicrobial activity of these complexes against drug-resistant bacteria, particularly MRSA.
- To elucidate the mechanism of action and assess the resistance potential and in vivo efficacy of the most promising compound.
Main Methods:
- Synthesis and characterization of three novel ruthenium(II)-imidazole complexes.
- Determination of minimum inhibitory concentrations (MICs) against MRSA.
- Mechanistic studies including membrane integrity assays, ROS generation, DNA intercalation, and biofilm inhibition assays.
- Assessment of resistance development over serial passages and in vivo efficacy in a murine skin infection model.
Main Results:
- Ru-ctz exhibited potent activity against MRSA (MIC = 0.78 μM), outperforming clotrimazole, vancomycin, and daptomycin.
- Mechanistic studies revealed Ru-ctz disrupts bacterial membrane integrity, induces ROS, intercalates DNA, and inhibits biofilms.
- Ru-ctz showed minimal resistance development and demonstrated significant efficacy in accelerating wound healing and reducing inflammation in vivo.
Conclusions:
- Ru-ctz is a highly effective antimicrobial agent against MRSA with a novel multitarget mechanism.
- Its ability to overcome resistance and its favorable in vivo profile make it a promising therapeutic candidate.
- Further development of Ru-ctz could provide a vital new option for treating multidrug-resistant bacterial infections.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...